Marshall Wace, LLP Personalis, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Personalis, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 456,976 shares of PSNL stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
456,976
Previous 109,852
315.99%
Holding current value
$1.78 Million
Previous $128,000
1820.31%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PSNL
# of Institutions
91Shares Held
30.1MCall Options Held
27.5KPut Options Held
85.4K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.09MShares$27.6 Million0.36% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4MShares$15.6 Million8.7% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$12.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.44MShares$9.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$7.69 Million0.0% of portfolio
About Personalis, Inc.
- Ticker PSNL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 45,918,400
- Market Cap $179M
- Description
- Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...